Congress Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q3 | $362K | Buy |
|
|||||
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $56.7M | Sell |
|
|||||
2024
Q4 | $94.7M | Sell |
|
|||||
2024
Q3 | $95.3M | Sell |
|
|||||
2024
Q2 | $107M | Sell |
|
|||||
2024
Q1 | $130M | Sell |
|
|||||
2023
Q4 | $116M | Sell |
|
|||||
2023
Q3 | $128M | Sell |
|
|||||
2023
Q2 | $131M | Sell |
|
|||||
2023
Q1 | $122M | Sell |
|
|||||
2022
Q4 | $88.1M | Buy |
|
|||||
2022
Q3 | $88.2M | Buy |
|
|||||
2022
Q2 | $102M | Sell |
|
|||||
2022
Q1 | $145M | Sell |
|
|||||
2021
Q4 | $171M | Sell |
|
|||||
2021
Q3 | $165M | Sell |
|
|||||
2021
Q2 | $142M | Sell |
|
|||||
2021
Q1 | $113M | Sell |
|
|||||
2020
Q4 | $117M | Buy |
|
|||||
2020
Q3 | $114M | Sell |
|
|||||
2020
Q2 | $94.1M | Buy |
|
|||||
2020
Q1 | $818K | Buy |
|
|||||
2019
Q4 | $803K | Sell |
|
|||||
2019
Q3 | $804K | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $252K | Buy |
|